CELON PHARMA S.A. ZY-,10CELON PHARMA S.A. ZY-,10CELON PHARMA S.A. ZY-,10

CELON PHARMA S.A. ZY-,10

No trades
See on Supercharts
Market capitalization
‪182.66 M‬EUR
−0.080EUR
‪−8.38 M‬EUR
‪34.68 M‬EUR
‪21.03 M‬
Beta (1Y)
0.39

About CLNPHARMA

CEO
Maciej Wieczorek
Headquarters
Lomianki
Employees (FY)
523
Founded
2002
ISIN
PLCLNPH00015
FIGI
BBG00ZHRD7J4
Celon Pharma SA is a pharmaceutical company, which engages in the research and manufacture of modern drugs. The firm's products include Aromek, Donepex, Ketrel, Salmex, and Valzek. It operates through the Generic Drug and Innovative segments. The Generic Drug segment pertains to the manufacture and sale of drugs registered and authorized for marketing. The Innovative segment involves activities that develop the documentation on the basis of which a drug could be registered or commercialized at the stage prior to drug registration. The company was founded by Maciej Wieczorek on June 20, 2002 and is headquartered in Lomianki, Poland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CELON PHARMA S.A. ZY-,10 stocks are traded under the ticker 8RP.
CELON PHARMA S.A. ZY-,10 revenue for the last quarter amounts to ‪10.54 M‬ EUR despite the estimated figure of ‪11.26 M‬ EUR. In the next quarter revenue is expected to reach ‪12.43 M‬ EUR.
Yes, you can track CELON PHARMA S.A. ZY-,10 financials in yearly and quarterly reports right on TradingView.
8RP net income for the last quarter is ‪−1.47 M‬ EUR, while the quarter before that showed ‪2.06 M‬ EUR of net income which accounts for −171.43% change. Track more CELON PHARMA S.A. ZY-,10 financial stats to get the full picture.
Yes, 8RP dividends are paid annually. The last dividend per share was 0.02 EUR. As of today, Dividend Yield (TTM)% is 0.58%. Tracking CELON PHARMA S.A. ZY-,10 dividends might help you take more informed decisions.
Like other stocks, 8RP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CELON PHARMA S.A. ZY-,10 stock right from TradingView charts — choose your broker and connect to your account.
8RP reached its all-time high on Apr 19, 2021 with the price of 11.400 EUR, and its all-time low was 2.485 EUR and was reached on Oct 14, 2022. View more price dynamics on 8RP chart.
See other stocks reaching their highest and lowest prices.
As of May 4, 2024, the company has 523.00 employees. See our rating of the largest employees — is CELON PHARMA S.A. ZY-,10 on this list?
We've gathered analysts' opinions on CELON PHARMA S.A. ZY-,10 future price: according to them, 8RP price has a max estimate of 5.32 EUR and a min estimate of 2.78 EUR. Watch 8RP chart and read a more detailed CELON PHARMA S.A. ZY-,10 stock forecast: see what analysts think of CELON PHARMA S.A. ZY-,10 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CELON PHARMA S.A. ZY-,10 EBITDA is ‪−4.29 M‬ EUR, and current EBITDA margin is −15.78%. See more stats in CELON PHARMA S.A. ZY-,10 financial statements.